Exclusive patent, know-how and process license to research, develop, use, import, make, have made, sell, offer and sublicense products in the field of genetically modified bacteriophages using synthetic biology for human therapeutics to treat bacterial infections associated with acute and chronic wounds, to treat Pseudomonas aeruginosa lung infections, and to treat infections of Clostridium difficile, using licensor's 'UltraVector,' 'LEAP,' DNA and RNA MOD engineering, protein engineering, transcription control chemistry, genome engineering and cell system engineering technology and platforms.
RoyaltyStat · RoyaltyStat Library · 2019
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
RoyaltyStat Library · OpenAlex · article · 2019
Crossref supplies no abstract for this record; none is generated here.
Open the resolved locator · 10.34675/l28126
Metadata licence: OpenAlex metadata (CC0)